Timo K. van den Berg
Company: Byondis
Job title: Senior Director Immuno- Oncology
Seminars:
Closing Panel: The Future of Innate Immune Checkpoints & Activation 2:30 pm
Delving into the horizons of homing of innate cells and reprograming of the tumor microenvironment Discussing novel checkpoint inhibitors Analysing the various immunotherapy approaches discussed & beyond Updates on clinical trials for immunotherapies In vitro models and discovery technologies for innate cell-based therapies New methodologies of analyzing innate immune cells in the tumor microenvironment (scRNAseq,…Read more
day: Innate Immune Checkpoints & Activation Pre-Focus Day
Discovery & Development of Novel SIRPa Antibodies for Targeting of the CD47-SIRPa Myeloid Checkpoint 12:00 pm
day: Innate Immune Checkpoints & Activation Pre-Focus Day